Mitsubishi Tanabe, Pfizer to Copromote 5-in-1 Vaccine Gobik

Mitsubishi Tanabe Pharma said on January 23 that the company and Pfizer will jointly promote Gobik, a five-in-one combination vaccine against pertussis, diphtheria, tetanus, inactivated polio, and Hib (DTaP-IPV-Hib). Gobik was approved in March last year as the first five-in-one...read more